Van Leyen K, Kim H Y, Lee S R, et al. Baicalein and 12/15-lipoxygenase in the ischemic brain [J]. Stroke, 2006, 37:3014.
[3]
Lebeau A, Esclaire F, Rostene W, et al. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity [J]. Neuroreport, 2001, 12(10):2199.
[4]
Im H I, Joo W S, Nam E, et al. Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice [J]. J Pharmacol Sci, 2005,98:185.
Gao Z, Huang K, Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in SH-SY5Y cells [J]. Pharmacol Res,2001,43(2):173.
[8]
Mosley R L, Benner E J, Kadiu I, et al. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\'s disease [J]. Clin Neurosci Res, 2006,6(5):261.
[9]
Miller J A, Trout B R, Sullivan K A, et al. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons[J]. J Neurosci Res, 2011, 89(3):406.
[10]
Barnum C J, Tansey M G. Modeling neuroinflammatory pathogenesis of Parkinson\'s disease [J]. Prog Brain Res, 2010,184:113.
[11]
Miklossy J, Doudet D D, Schwab C, et al. Role of ICAM-1 in persisting inflammation in Parkinson\'s disease and MPTP monkeys [J]. Exp Neurol, 2006,1 97(2): 275.
Hsieh C J, Hall K, Ha T, et al. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway [J]. Clin Mol Allergy, 2007,5: 5.
[14]
Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6[J]. Biochim Biophys Acta, 2011,1813(15):878.
[15]
Conductier G, Blondeau N, Guyon A, et al. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases [J]. J Neuroimmunol, 2010,224(1/2):93.
[16]
Kaneko T, Chiba H, Horie N, et al. Effect of Scutellariae Radix ingredients on prostaglandin E(2) production and COX-2 expression by LPS-activated macrophage[J]. In Vivo, 2009,23(4):577.
[17]
Li F Q, Wang T, Pei Z, et al. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons [J]. J Neural Transm, 2005,12(3):331.
[18]
Gao Z H, Huang H, Yang X L, et al. Free radical scavenging and antionxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi [J]. Biochim Biophys Acta, 1999,1472(3):643.
[19]
Zhang S, Ye J, Dong G. Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells [J]. J Mol Neurosci, 2010,40(3):311.
Cartelli D, Ronchi C, Maggioni M G, et al. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+- induced neurodegeneration[J]. J Neurochem, 2010,115(1):247.
[22]
Banerjee R, Starkov A A, Beal M F, et al. Mitochondrial dysfunction in the limelight of Parkinson\'s disease pathogenesis[J]. Biochim Biophys Acta, 2009, 1792(7):651.
[23]
Haas R, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/ III activity in early unt reated Parkinson\'s disease[J]. Ann Neurol, 1995,37: 714.
[24]
Kyung Leea, Kyoung Ah Kangb, Rui Zhangb, et al. Mitochondria protection of baicalein against oxidative damage via induction of manganese superoxide dismutase[J]. Environ Toxicol Pharmacol, 2011,31: 233.
[25]
He X L, Wang Y H, Gao M, et al. Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage [J]. Brain Res, 2009,1249:212.
[26]
Bender C, Rassetto M, de Olmos J S, et al. Involvement of AMPA/kainate-excitotoxicity in MK801-induced neuronal death in the retrosplenial 楣獯慲杴来牸攠杛慊瑝攮猠?敥硵楲獯瑳楣湩来?晣楥戬爠椲氰猱‰嬬?崶?????椷漲氰??桢敲派?″特そ???????㈠???????????执牥?孭??崠??祐漬?剥??乡慬欮愠?桯慬瑥?乯??卥慸正慩歴楡扴慯牲慹????敮瑯?慡汣???慴楲捡慮汳楰湯?慴湥摲?戲愠椨捅慁汁敔椲温??据潤渠獧瑬極瑴畡瑭敡湴瑥猠?潮映?慥湵?楯浤灥潧牥瑮慥湲瑡?浩敯摮椺挠楯湰慰汯?灴汵慮湩瑴??楳渠桦楯扲椠瑤?楶湥瑬牯慰捩敮汧氠畮汯慶牥??慴?獥畲灡?????獣畳灛??攮氠敊瘠慃瑥楬潬渠?扨祹?物敯摬甬挠椲渰朱‰瀬栠漲猲瀶栨漱氰椩瀺愲猴攸???慢捲琾楛瘳椶瑝礠?楥湲????爠慇琠?本氠楔潯浴慴?捲敤汥汬獬?孓?崠????健桳愠浍?倠桥慴爠浡慬挮漠汉????????で???ち???????meostasis and programmed cell death in a chronic MPTP mouse model of Parkinson\'s disease [J]. Exp Neurol,2009,219: 334.
[27]
Lee H H, Yang L L, Wang C C, et al. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death [J]. Brain Res, 2003,986(1/2): 103.
[28]
Ge Q F, Hu X, Ma Z Q, et al. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons [J]. Pharmacol Res,2007,55(2):148.
[29]
成银霞. 抗帕金森病新药的发现与评价 . 北京:中国医学科学院协和医科大学, 2008.
[30]
Masliah E, Rockenstein E, Adame A, et al. Effects of α-synuclein immunization in a mouse model of Parkinson\'s disease [J]. Neuron, 2005, 46(6):857.
[31]
Alberio T, Bossi A M, Milli A, et al. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson\'s disease pathogenesis[J]. FEBS J, 2010,277(23):4909.
[32]
Lu J H, Ardah M T, Durairajan S S, et al. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation[J]. Chem Biochem 2011, 12(4):615.
[33]
Jiang M, Porat-Shliom Y, Pei Z, et al. Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism [J]. J Neurochem, 2010, 114 (2):419.
Zhu M, Rajamani S, Kaylor J, et al. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and d
[37]
Lu J, Wang J S, Kong L Y. Anti-inflammatory effects of Huang-Lian-Jie-Du Decoction, its two fractions and four typical compounds [J]. J Ethnopharmacol, 2011, 134(3):911.
[38]
Hwang J M, Tseng T H, Tsal Y Y, et al. Protective elects of baicalein on tert--butyl hydroperoxide-induced hepatic toxicity in rat hepatocytes[J]. Biomed Sci, 2005,12(2): 389.
[39]
Dou J, Chen L, Xu G, et al . Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase [J]. Arch Virol, 2011, 156(5):793.
[40]
Yun M Y, Yang J H, Kim D K, et al. Therapeutic effects of baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus[J]. Int Immunopharmacol, 2010,10(9):1142.
[41]
Liu J H, Wann H, Chen M M, et al. Baicalein significantly protects human retinal pigment epithelium cells against H2O2-induced oxidative stress by scavenging reactive oxygen species and downregulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor[J]. J Ocul Pharmacol Ther, 2010,26 (5):421.
[42]
Schiess M C, Barnes J L, Ellmore T M, et al. CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes [J]. Brain Res, 2010,11:151.
[43]
Qian L, Flood P M, Hong J S. Neuroinflammation is a key player in Parkinson\'s disease and a prime target for therapy [J]. J Neural Transm, 2010,117(8):971.
[44]
Hunot S, Hirsch E C. Neuroinflammatory processes in Parkinson\'s disease [J]. J Ann Neuro, 2003,53 (3):492.
